Jeffrey W. Sherman
Director at Xeris Biopharma Holdings · 4 reported transactions in 2 companies · latest trade Feb 27, 2026
Their record
Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move −28.8%, S&P 500 +10.9% over the same days.
Their trades
Bought | Feb 27, 2026 | Feb 27, 2026 close $5.31 → Oct 30, 2026 close $2.52. S&P 500 +12.6% over the same days. | ||
Sold | Aug 28, 2025 | Aug 28, 2025 close $7.90 → Oct 29, 2026 close $10.75. S&P 500 +19.0% over the same days. |
BoughtLarimar Therapeutics
$25K
Feb 27, 2026 close $5.31 → Oct 30, 2026 close $2.52. S&P 500 +12.6% over the same days.
$334.5K
Aug 28, 2025 close $7.90 → Oct 29, 2026 close $10.75. S&P 500 +19.0% over the same days.